CLINICAL_TRIALS
trial_result
· 2017-03-09
Clinical Trial Update: Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention [Phase 2]
Summary
This update reports the termination of a Phase 2 study of lovastatin for breast cancer chemoprevention, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-03-09